What are the AHA/ASA guidelines for antithrombotic therapy in transient ischemic attack (TIA) with mitral valve prolapse?

Updated: Dec 03, 2018
  • Author: Ashish Nanda, MD; Chief Editor: Andrew K Chang, MD, MS  more...
  • Print

In mitral valve prolapse, long-term antiplatelet therapy is reasonable. In mitral annular calcification, antiplatelet therapy can be considered. Patients with mitral regurgitation can be considered for warfarin or antiplatelet therapy.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!